These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 10440801

  • 1. Evolution of wild-type and precore mutant HBV infection after liver transplantation.
    Torre F, Wong PY, Macartney M, Williams R, Naoumov NV.
    J Med Virol; 1999 Sep; 59(1):5-13. PubMed ID: 10440801
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
    Ben-Ari Z, Zemel R, Kazetsker A, Fraser G, Tur-Kaspa R.
    Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation.
    Flowers M, Sherker A, Sinclair SB, Greig PD, Cameron R, Phillips MJ, Blendis L, Chung SW, Levy GA.
    Transplantation; 1994 Jul 27; 58(2):183-92. PubMed ID: 8042236
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
    Yang Y, Yang Y, Zhang J, Yi HM, Lu MQ, Cai CJ, Li X, Jiang N, Xu C, Li H, Wang GS, Yi SH, Zhang JF, Jiang H, Yang Q, Chen GH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct 27; 28(10):1810-2. PubMed ID: 18971179
    [Abstract] [Full Text] [Related]

  • 17. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ, Yoo BC.
    Taehan Kan Hakhoe Chi; 2002 Jun 27; 8(2):149-56. PubMed ID: 12499800
    [Abstract] [Full Text] [Related]

  • 18. Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation.
    Hussain M, Soldevila-Pico C, Emre S, Luketic V, Lok AS, NIH HBV-OLT Study Group.
    Liver Transpl; 2007 Aug 27; 13(8):1137-44. PubMed ID: 17663390
    [Abstract] [Full Text] [Related]

  • 19. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
    Caccamo L, Romeo R, Rossi G, Maggioni M, Radice F, Lunghi G, Colombo M, Fassati LR.
    Transpl Int; 2005 Feb 27; 18(2):186-92. PubMed ID: 15691271
    [Abstract] [Full Text] [Related]

  • 20. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S, Velu V, Nandakumar S, Madhavan V, Shanmugasundaram U, Shankar EM, Murugavel KG, Balakrishnan P, Kumarasamy N, Solomon S, Thyagarajan SP.
    J Microbiol Biotechnol; 2008 Oct 27; 18(10):1722-8. PubMed ID: 18955826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.